CareCloud (CCLD) Stock: Buy, Sell, or Hold?
CCLD - CareCloud, Inc. Common Stock
$2.15
0.00 (0.00%)
▲
5d:
+4.88%
30d:
-14.34%
90d:
-2.71%
HOLD
LOW Confidence
Analysis Updated: Sep 22, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When CCLD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CCLD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CCLD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.29
Based on -6.2% avg growth
INTRINSIC VALUE TODAY
$1.42
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CCLD is currently trading at $2.15, which is considered slightly low relative to its 30-day fair value range of $2.11 to $2.53. From a valuation perspective, the stock is trading at a discount (Forward PE: 7.0) compared to its historical average (10.5). Remarkably, the market is currently pricing in an annual earnings decline of 12.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CCLD is in a uptrend. Immediate support is located at $2.03, while resistance sits at $2.23.
Market Sentiment: CCLD scores 92/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.33 (+241.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CCLD is in a uptrend. Immediate support is located at $2.03, while resistance sits at $2.23.
Market Sentiment: CCLD scores 92/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.33 (+241.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.11 -
$2.53
Company Quality Score
71/100
(BUY)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
86.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BULLISH: Strong technical setup (92/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 241.1% below Wall St target ($7.33)
- CAUTION: Bottoming setup, but lagging the sector by 25% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$2.11 -
$2.53
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$0.23
(10.9%)
Support & Resistance Levels
Support Level
$2.03
Resistance Level
$2.23
Current Trend
Uptrend
Technical data as of
Sep 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.05
Wall Street Target
$7.33
(+241.1%)
Revenue Growth (YoY)
16.4%
Earnings Growth (YoY)
-88.3%
Profit Margin
6.2%
Valuation Discount vs History
-12.5% cheaper
PE vs Historical
7.1 vs 10.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-12.5%
(market-implied from PE analysis)
1-Year Target
$1.94
(-10%)
2-Year Target
$1.74
(-19%)
3-Year Target
$1.57
(-27%)
3-Yr Target (if PE normalizes)
(PE: 7→11)
$2.33
(+9%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: -16.4%)
$4.50
(+109%)
Base:
(SPY PE: 7.0, Growth: -16.4%)
$1.57
(-27%)
Bear:
(PE: 6.0, Growth: -16.4%)
$1.33
(-38%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (31x PE), but valuation improves significantly next year (7x PE) as earnings recover.
Trailing PE: 31.00 | Current EPS (TTM): $0.07
Bull Case
$4.77
(+122%)
Analyst growth 100.0%, PE expands to 34.1
Base Case
$4.34
(+102%)
Market implied 100.0%, PE stable at 31.0
Bear Case
$1.48
(-31%)
Severe decline -20.0%, PE contracts to 26.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.0 to 10.5
Stabilization Target:
$3.20
(+49.0%)
PE Expansion Potential:
+49.0%
Share & Embed Analysis
Last updated: September 22, 2026 4:47 PM ET
Data refreshes hourly during market hours. Next update: 5:47 PM
Data refreshes hourly during market hours. Next update: 5:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCLD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$297 | 42 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 60 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 65 BUY |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 29 SELL |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 58 HOLD |
